ΔΗΜΟΣΙΕΥΣΕΙΣ
Cervical, uterine corpus, and ovarian cancer mortality in Greece during 1980 to 2005: a trend analysis
Pavlidou E, Zafrakas M, Papadakis N, Benos A, Agorastos T.
Effect of type-specific human papillomavirus incidence on screening performance and cost
Agorastos T, Sotiriadis A, Emmanouilides CJ.
Safety of human papillomavirus (HPV) vaccines: a review of the international experience so far
Agorastos T, Chatzigeorgiou K, Brotherton JM, Garland SM.
Prevalence and distribution of high-risk human papillomavirus in Greece
Agorastos T, Lambropoulos AF, Sotiriadis A, Mikos T, Togaridou E, Emmanouilides CJ.
TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies
Klug SJ, Ressing M, Koenig J, Abba MC, Agorastos T, Brenna SM, Ciotti M, Das BR, Del Mistro A, Dybikowska A, Giuliano AR, Gudleviciene Z, Gyllensten U, Haws AL, Helland A, Herrington CS, Hildesheim A, Humbey O, Jee SH, Kim JW, Madeleine MM, Menczer J, Ngan HY, Nishikawa A, Niwa Y, Pegoraro R, Pillai MR, Ranzani G, Rezza G, Rosenthal AN, Roychoudhury S, Saranath D, Schmitt VM, Sengupta S, Settheetham-Ishida W, Shirasawa H, Snijders PJ, Stoler MH, Suarez-Rincon AE, Szarka K, Tachezy R, Ueda M, van der Zee AG, von Knebel Doeberitz M, Wu MT, Yamashita T, Zehbe I, Blettner M.
Long-term follow-up after cervical cancer treatment and subsequent successful surrogate pregnancy
Agorastos T, Zafrakas M, Mastrominas M.
